These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17617651)

  • 21. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
    Block GA; Raggi P; Bellasi A; Kooienga L; Spiegel DM
    Kidney Int; 2007 Mar; 71(5):438-41. PubMed ID: 17200680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of heart valve calcification with malnutrition-inflammation complex syndrome, beta-microglobulin, and carotid intima media thickness in patients on hemodialysis.
    Ikee R; Honda K; Oka M; Maesato K; Mano T; Moriya H; Ohtake T; Kobayashi S
    Ther Apher Dial; 2008 Dec; 12(6):464-8. PubMed ID: 19140844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirty-month follow-up of coronary artery calcification in hemodialysis patients: different roles for inflammation and abnormal calcium-phosphorous metabolism?
    Patsalas S; Eleftheriadis T; Spaia S; Theodoroglou H; Antoniadi G; Liakopoulos V; Passadakis P; Vayonas G; Vargemezis V
    Ren Fail; 2007; 29(5):623-9. PubMed ID: 17654327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of malnutrition on mortality in patients on maintenance hemodialysis in Serbia.
    Stojanovic M; Stojanovic D; Stefanovic V
    Artif Organs; 2008 May; 32(5):398-405. PubMed ID: 18471169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Yang Q; Pieper KS; Antman EM; White HD; Goodman SG; Cohen M; Kleiman NS; Langer A; Aylward PE; Col JJ; Reist C; Ferguson JJ; Califf RM;
    J Gen Intern Med; 2008 Mar; 23(3):310-6. PubMed ID: 18196350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in end stage renal disease: calcium carbonate vs. sevelamer.
    Borzecki AM; Lee A; Wang SW; Brenner L; Kazis LE
    J Clin Pharm Ther; 2007 Dec; 32(6):617-24. PubMed ID: 18021340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
    Trivedi H; Xiang Q; Klein JP
    Nephrol Dial Transplant; 2009 Jan; 24(1):258-66. PubMed ID: 18682489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
    Joki N; Tanaka Y; Ishikawa H; Takahashi Y; Iwakura Y; Masuda H; Inishi Y; Hase H
    Am J Nephrol; 2009; 29(5):420-5. PubMed ID: 18997458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.
    Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK
    Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction.
    Halkos ME; Chen EP; Sarin EL; Kilgo P; Thourani VH; Lattouf OM; Vega JD; Morris CD; Vassiliades T; Cooper WA; Guyton RA; Puskas JD
    Ann Thorac Surg; 2009 Sep; 88(3):746-51. PubMed ID: 19699891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients.
    Liu S; Zhang DL; Guo W; Cui WY; Liu WH
    Hemodial Int; 2012 Oct; 16(4):504-11. PubMed ID: 22520823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of serum macrophage colony-stimulating factor for development of aortic calcification in haemodialysis patients: a 6 year longitudinal study.
    Kihara T; Miyata Y; Furukawa M; Noguchi M; Nishikido M; Koga S; Kanetake H
    Nephrol Dial Transplant; 2005 Aug; 20(8):1647-52. PubMed ID: 15919699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
    Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.
    Roberts MA; Thomas MC; Fernando D; Macmillan N; Power DA; Ierino FL
    Nephrol Dial Transplant; 2006 Jun; 21(6):1611-7. PubMed ID: 16520354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
    Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum phosphate predicts mortality in renal transplant recipients.
    Connolly GM; Cunningham R; McNamee PT; Young IS; Maxwell AP
    Transplantation; 2009 Apr; 87(7):1040-4. PubMed ID: 19352125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.